RCT Face-to-face Group Voice Therapy vs Telepractice Group Voice Therapy for Muscle Tension Dysphonia

Launched by CHINESE UNIVERSITY OF HONG KONG · Jul 26, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to provide voice therapy for people with muscle tension dysphonia (MTD), a condition that affects how the voice sounds. The researchers want to find out if group voice therapy delivered in person is as effective as therapy offered through telepractice, which means therapy sessions conducted online. Participants will be randomly assigned to either the face-to-face group or the telepractice group to see how well each method helps improve their voice.

To be eligible for this study, participants need to be at least 18 years old, speak Chinese, and have a diagnosis of muscle tension dysphonia where voice therapy is the main treatment. It's important to note that people with certain other voice problems or those who aren't comfortable using technology may not be able to participate. If you join the study, you can expect to receive voice therapy either in a group setting in person or through a virtual platform, and you’ll help researchers understand which method works better for treating MTD. The trial is currently recruiting participants, so if you or someone you know is interested, it could be a great opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Above or equal to 18 years of age;
• • Diagnosis of primary MTD or secondary MTD where voice therapy is the primary mode of treatment, such as vocal fold nodules;
• • Chinese-speaking subjects only.
• Exclusion Criteria:
• • Dysphonia of neurogenic or psychogenic origin;
• • Secondary muscle tension dysphonia in which voice therapy is not the primary treatment modality, such as vocal polyp, vocal cyst, granuloma, papilloma;
• • Low computer literacy or without social or family support for telepractice;
• • Patients who are not capable of making own consent;
• • Patients who are receiving other modalities of treatment which is not part of this current study, such as traditional Chinese medicine.